A Citywide Approach to SARS-CoV2 Testing
Copyright © 2021 Broach, Lowell, Brown, Martin, Muller, Shirshac, Perrone, Smith, Castiel, Kobayashi, Lapriore, Dickson and Babu..
The COVID-19 pandemic caused more than 30 million infections in the United States between March 2020 and April 2021. In response to systemic disparities in SARS-CoV2 testing and COVID-19 infections, health systems, city leaders and community stakeholders in Worcester, Massachusetts created a citywide Equity Task Force with a specific goal of making low-barrier testing available to individuals throughout our community. Within months, the state of Massachusetts announced the Stop the Spread campaign, a state-funded testing venture. With this funding, and through our community-based approach, our team tested more than 48,363 individuals between August 3, 2020 and February 28, 2021. Through multiple PDSA (Plan-Do-Study-Act) cycles, we optimized our process to test close to 300 individuals per hour. Our positivity rate ranged from 1.5% with our initial testing events to a high of 13.4% on January 6, 2021. During the challenges of providing traditional inpatient and ambulatory care during the pandemic, our health system, city leadership, and community advocacy groups united to broaden the scope of care to include widespread, population-based SARS-CoV2 testing. We anticipate that the lessons learned in conducting this testing campaign can be applied to further surges of SARS-CoV2, international environments, and future respiratory disease pandemics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Frontiers in public health - 9(2021) vom: 30., Seite 695442 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Broach, John P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 21.07.2021 Date Revised 21.07.2021 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fpubh.2021.695442 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328229083 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328229083 | ||
| 003 | DE-627 | ||
| 005 | 20231225202521.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpubh.2021.695442 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328229083 | ||
| 035 | |a (NLM)34277553 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Broach, John P |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Citywide Approach to SARS-CoV2 Testing |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2021 | ||
| 500 | |a Date Revised 21.07.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Broach, Lowell, Brown, Martin, Muller, Shirshac, Perrone, Smith, Castiel, Kobayashi, Lapriore, Dickson and Babu. | ||
| 520 | |a The COVID-19 pandemic caused more than 30 million infections in the United States between March 2020 and April 2021. In response to systemic disparities in SARS-CoV2 testing and COVID-19 infections, health systems, city leaders and community stakeholders in Worcester, Massachusetts created a citywide Equity Task Force with a specific goal of making low-barrier testing available to individuals throughout our community. Within months, the state of Massachusetts announced the Stop the Spread campaign, a state-funded testing venture. With this funding, and through our community-based approach, our team tested more than 48,363 individuals between August 3, 2020 and February 28, 2021. Through multiple PDSA (Plan-Do-Study-Act) cycles, we optimized our process to test close to 300 individuals per hour. Our positivity rate ranged from 1.5% with our initial testing events to a high of 13.4% on January 6, 2021. During the challenges of providing traditional inpatient and ambulatory care during the pandemic, our health system, city leadership, and community advocacy groups united to broaden the scope of care to include widespread, population-based SARS-CoV2 testing. We anticipate that the lessons learned in conducting this testing campaign can be applied to further surges of SARS-CoV2, international environments, and future respiratory disease pandemics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV2 | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a public health | |
| 650 | 4 | |a testing | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 700 | 1 | |a Lowell, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, Clayton |e verfasserin |4 aut | |
| 700 | 1 | |a Muller, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Shirshac, Jeanne |e verfasserin |4 aut | |
| 700 | 1 | |a Perrone, Domenica |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Will |e verfasserin |4 aut | |
| 700 | 1 | |a Castiel, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Kimiyoshi J |e verfasserin |4 aut | |
| 700 | 1 | |a Lapriore, Cheryl M |e verfasserin |4 aut | |
| 700 | 1 | |a Dickson, Eric W |e verfasserin |4 aut | |
| 700 | 1 | |a Babu, Kavita M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 9(2021) vom: 30., Seite 695442 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g day:30 |g pages:695442 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2021.695442 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |b 30 |h 695442 | ||